To investigate the effects of SREBP1c on TAA‐induced liver fibrosis, two groups of mice were received AdSREBP1c or the Adcontrol following one week of TAA treatment and then were treated with TAA for another 3 weeks. This evidence concerns the gene SREBF1 and Hepatic fibrosis.